Long term subcutaneous tinzaparin compared with tinzaparin and oral anticoagulants in the treatment of acute pulmonary embolism. A multicentre, prospective, randomised, open, parallel group clinical trial.
ESTADO CLÍNICO
En marcha
FASE/S DEL ENSAYO
Fase IV
PATOLOGÍA
Trombosis y Anticoagulantes
FECHA DE APERTURA
Diciembre, 2005
FECHA DE CIERRE
,
CRITERIOS DE INCLUSIÓN
Patients with clinical suspicion of Pulmonar Thromboembolism confirmed according to the PIOPED criteria.
CRITERIOS DE EXCLUSIÓN
4.0
DESCRIPCIÓN
The efficacy of both treatments will be evaluated with the number of thromboembolic recurrences for each drug.
PALABRAS CLAVE
direct oral anticoagulants, thromboembolic disease
